Business intelligence and swine flu … it sounds like a random Google search. In reality, though, as companies race to deliver vaccines for swine flu, business intelligence can play a role in helping to get this vital drug to market faster. How so? … Continue reading below the video >>
Several weeks ago two Chinese biotechs received samples of A/H1N1 and have begun clinical trials for the vaccine. Sinovac Biotech Ltd (SVA) and Hualan Biological Engineering are testing their vaccines and have stated they expect to announce results in September.
Without being privy to what they are actually doing, let’s take a look at information made public by these drug developers, and see where business intelligence software can provide an edge – be it time-to-market, safety, or more.
Both drug companies are in clinical trials on a few variants of vaccines, on a large number of people and in different doses.
Business intelligence software could help manage this vital process. Here’s how:
- Business intelligence software allows companies to spot potential safety issues earlier in the development process by providing a faster and more flexible environment;
- Business intelligence software provides easy point-and-click creation of advanced clinical graphics;
- Business intelligence software can be easily integrated with existing exploratory, presentation and production environments; and more.
In fact, clinical trials that use business intelligence find that they:
- Can analyze data earlier in the trial;
- See data in context;
- Drill down to patient-level details;
- Combine data from different trials and projects; and
- Handle clinical data and genomic data.
In addition, BI can be used to track outbreaks of the virus itself. Here is a look at that side of the issue.
Have you used business intelligence software to manage your clinical trials? Tell us your experiences in the comments section.
Kelley Kassa and Sunny Gault
Spotfire Blogging Team